1. A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas. Issue 10 (3rd October 2017) Authors: Sborov, Douglas W.; Canella, Alessandro; Hade, Erinn M.; Mo, Xiaokui; Khountham, Soun; Wang, Jiang; Ni, Wenjun; Poi, Ming; Coss, Christopher; Liu, Zhongfa; Phelps, Mitch A.; Mortazavi, Amir; Andritsos, Leslie; Baiocchi, Robert A.; Christian, Beth A.; Benson, Don M.; Flynn, Joseph; Porcu, Pierluig... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 10(2017) Page Start: 2310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma. Issue 9 (2nd September 2017) Authors: Cohen, Jonathon B.; Maddocks, Kami J.; Huang, Ying; Christian, Beth A.; Jaglowski, Samantha M.; Flowers, Christopher R.; Blum, Kristie A. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 9(2017) Page Start: 2268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma. Issue 7 (7th June 2022) Authors: Bond, David A.; Huang, Ying; Christian, Beth A.; Jaglowski, Samantha; Benson, Don; Alinari, Lapo; Baiocchi, Robert A.; Cohen, Jonathon B.; Blum, Kristie A.; Maddocks, Kami J. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 7(2022) Page Start: 1750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014) Authors: Cohen, Jonathon B.; Geyer, Susan M.; Lozanski, Gerard; Zhao, Weiqiang; Heerema, Nyla A.; Hall, Nathan C.; Nagar, Veena A.; Hemminger, Jessica A.; Jones, Jeffrey A.; Porcu, Pierluigi; Christian, Beth A.; Baiocchi, Robert A.; Maddocks, Kami J.; Flynn, Joseph M.; Devine, Steven M.; Blum, Kristie A. Journal: Cancer Issue: Volume 120:Issue 11(2014) Page Start: 1677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival. Issue 11 (27th February 2014) Authors: Cohen, Jonathon B.; Geyer, Susan M.; Lozanski, Gerard; Zhao, Weiqiang; Heerema, Nyla A.; Hall, Nathan C.; Nagar, Veena A.; Hemminger, Jessica A.; Jones, Jeffrey A.; Porcu, Pierluigi; Christian, Beth A.; Baiocchi, Robert A.; Maddocks, Kami J.; Flynn, Joseph M.; Devine, Steven M.; Blum, Kristie A. Journal: Cancer Issue: Volume 120:Issue 11(2014) Page Start: 1677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose. Issue 7 (3rd July 2017) Authors: Bond, David A.; Huang, Ying; Ruppert, Amy S.; Walker, Alison R.; Dotson, Emily K.; Roddy, Julianna; Blum, Kristie A.; Christian, Beth A. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 7(2017) Page Start: 1589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The combination of milatuzumab, a humanized anti‐CD74 antibody, and veltuzumab, a humanized anti‐CD20 antibody, demonstrates activity in patients with relapsed and refractory B‐cell non‐Hodgkin lymphoma. (7th April 2015) Authors: Christian, Beth A.; Poi, Ming; Jones, Jeffrey A.; Porcu, Pierluigi; Maddocks, Kami; Flynn, Joseph M.; Benson, Don M.; Phelps, Mitch A.; Wei, Lai; Byrd, John C.; Wegener, William A.; Goldenberg, David M.; Baiocchi, Robert A.; Blum, Kristie A. Journal: British journal of haematology Issue: Volume 169:Number 5(2015:Jun.) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗